GSK plc Announces Share Buyback Transaction

GSK plc has announced the purchase of 555,000 of its ordinary shares at a volume-weighted average price of 1,619.90p per share on 24 October 2025. This transaction is part of the company's existing buyback program, which has seen the purchase of 6,282,500 ordinary shares since 30 September 2025. Following this purchase, GSK will hold 253,747,344 ordinary shares in treasury, with 4,061,673,442 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the company is 4,061,673,442, with 6.25% of voting rights attributable to the treasury shares. The shares were purchased through BNP Paribas SA on the London Stock Exchange and CBOE Europe Limited.